Volume 1, Number 4, January 2005

Optimising lipid levels: looking beyond LDL-cholesterol
Sue Lyon

Treatment with statins is undoubtedly making a major contribution to reducing high-risk patients’ chance of a heart attack or another coronary event. However, their risk remains high, since over half of patients included in statin clinical trials suffered a further coronary event within five years. There is growing evidence that we need to move beyond simply lowering low-density lipoprotein cholesterol (LDL-C) and optimise the whole lipid profile.

View full PDF article (open in new window)
Email this article